Bio-Rad Laboratories, Inc. Class A Common Stock vs International Business Machines Corp — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while International Business Machines Corp trades at $237.35 (market cap $224.62B). The key difference: International Business Machines Corp is far larger — about 23.8× Bio-Rad Laboratories, Inc. Class A Common Stock's market cap, and International Business Machines Corp pays a 2.84% dividend while Bio-Rad Laboratories, Inc. Class A Common Stock pays none. Which is the better fit depends on your goals.
| BIO | IBM | |
|---|---|---|
Market Cap | $9.43B | $224.62B |
Sector | Health | Technology |
52-Week High | $356.25 | $329.23 |
52-Week Low | $241.71 | $205.77 |
Enterprise Value | $9.18B | $281.76B |
Volume | — | 4,481,527 |
Dividend Yield | — | 2.84% |
Trailing returns across standard periods
Latest headlines on both assets
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →International Business Machines Corporation (IBM) provides computer solutions. The Company offers application, technology consulting and support, process design and operations, cloud, digital workplace, and network services, as well as business resiliency, strategy, and design solutions. IBM serves clients worldwide.
Read more on IBM →